NCT01514942View on ClinicalTrials.gov

Myo-inositol Versus D-chiro-inositol in the Treatment of Polycystic Ovary Syndrome and Insulin Resistance: Evaluation of Clinical, Metabolic, Endocrine and Ultrasound Parameters

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
PCOS
Interventions
DIETARY_SUPPLEMENT

Myo-inositol + Folic acid

Myo-inositol (2g) Folic acid (200mcg) (2 per day)

DIETARY_SUPPLEMENT

Myo-inositol + Folic acid

Myo-inositol (2g) Folic acid (200mcg) (2 per day)

DIETARY_SUPPLEMENT

D-chiro-inositol, manganese, folic acid, vit B12

D-Chiro-inositol (500 mg), manganese (1 mg), folic acid (200 mcg), vit B12 (1.25 mcg) (2 per day)

DIETARY_SUPPLEMENT

D-chiro-inositol, manganese, folic acid, vit B12

D-chiro-inositol (500 mg), manganese (1 mg), folic acid (200 mcg), vit B12 (1.25 mcg) (2 per day)

DRUG

Folic acid, vit B12

Folic acid (200 mcg), vit B12 (1.25 mcg) (2 per day)

DRUG

Folic acid, vit B12

Folic acid (200 mcg), vit B12 (1.25 mcg) (2 per day)

Trial Locations (1)

Unknown

Istituto di Patologia Ostetrica e Ginecologica, Catania

All Listed Sponsors
lead

AGUNCO Obstetrics and Gynecology Centre

OTHER